Maxion Therapeutics

Developer of a novel platform designed to generate antibody-like therapeutics to solve ion channel and GPCR-driven diseases. The company combines mini-proteins found in venom and other sources called ...

Healthcare

Cambridge, United Kingdom

Founded 2020

50 employees

Website

Valuation

$110.6M

Market implied

Share Price

N/A

Total Raised

$105.1M

Last Round

N/A

Investors

+8 other investors

View all 8 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Maxion Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required